Ziemann Malte, Sedemund-Adib Beate, Reiland Petra, Schmucker Peter, Hennig Holger
Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Crit Care Med. 2008 Dec;36(12):3145-50. doi: 10.1097/CCM.0b013e31818f3fc4.
To determine the prevalence and impact on patient outcome of active human cytomegalovirus infections in patients with prolonged treatment in an intensive care unit.
Retrospective analysis of stored plasma samples.
Anesthesiological intensive care unit of a university hospital.
All 138 patients treated for at least 14 days (of a total of 4940 patients admitted during the study period). Immunocompromised patients and patients with inconclusive results for cytomegalovirus DNA were excluded.
None.
Stored plasma samples of patients with prolonged intensive care unit stay were tested for cytomegalovirus DNA. Sixty-four of 255 evaluable samples from 99 immunocompetent patients tested cytomegalovirus DNA-positive with a mean DNA concentration of 8,600 genome equivalents per milliliter. Active cytomegalovirus infection was diagnosed by reproducibly positive results in 35 patients (35%). Only one case had been diagnosed clinically. Patients with and without active cytomegalovirus infection were not significantly different in parameters, such as age, sex, admission category, source of admission, or comorbidities. Even review of specific surgical procedures or the use of a heart-lung-machine showed no significant differences between the groups. The mortality rate in patients with cytomegalovirus infection was significantly increased (28.6% vs. 10.9%, p = 0.048), and surviving patients had a longer intensive care unit stay (32.6 vs. 22.1 days, p <0.001).
Active cytomegalovirus infection is a frequent but seldom diagnosed finding in surgical patients with prolonged intensive care unit stay, which is associated with increased mortality and prolonged intensive care unit stay of surviving patients.
确定重症监护病房中接受长期治疗的患者活动性人巨细胞病毒感染的患病率及其对患者预后的影响。
对储存的血浆样本进行回顾性分析。
一所大学医院的麻醉重症监护病房。
研究期间收治的4940例患者中,所有接受至少14天治疗的138例患者。免疫功能低下患者和巨细胞病毒DNA检测结果不确定的患者被排除。
无。
对重症监护病房住院时间延长的患者的储存血浆样本进行巨细胞病毒DNA检测。99例免疫功能正常患者的255份可评估样本中,64份检测出巨细胞病毒DNA呈阳性,平均DNA浓度为每毫升8600个基因组当量。35例患者(35%)通过反复检测呈阳性结果确诊为活动性巨细胞病毒感染。仅1例为临床诊断。有或无活动性巨细胞病毒感染的患者在年龄、性别、入院类别、入院来源或合并症等参数方面无显著差异。即使对特定手术操作或心肺机的使用情况进行回顾,两组之间也无显著差异。巨细胞病毒感染患者的死亡率显著升高(28.6%对10.9%,p = 0.048),存活患者的重症监护病房住院时间更长(32.6天对22.1天,p<0.001)。
活动性巨细胞病毒感染在重症监护病房住院时间延长的外科患者中很常见,但很少被诊断出来,这与死亡率增加和存活患者的重症监护病房住院时间延长有关。